SCAFFOLDS AS DRUG AND BIOACTIVE COMPOUND DELIVERY SYSTEMS

Abstract

The article updates the existing data on the use of scaffolds as target and controlled substance delivery systems. The prerequisites and grounds for using scaffolds as substance delivery systems are being considered. Current tissue-engineered strategies for developing target drug and bioactive substance delivery using scaffolds are being discussed. A classification of scaffold-based substance delivery systems is provided. Special attention is given to the development of two-phase substance delivery systems using various types of nanoparticles. A variety of nanoparticles and the benefits of their use as carriers of substances in a two-component delivery systems are shown. Recent developments in the substance delivery systems for regenerative medicine and future prospects are presented.